The Latest Legal and Regulatory Developments Strategies for Cost-Effective, High Value, Low Risk FTO Assessments
An effective Freedom to Operate 2010 search strategy and evaluation method is vital to the pharmaceutical, biotech and chemical industry. If you do not have a sound strategy, future revenue is at stake and you severely increase the threat of litigation. It is critical that IP counsel and legal advisors in the pharmaceutical and biotech industries have the information they need to create a successful FTO analysis which not only protects them from risk but also maximises profit.
Only by identifying important patent issues and accurately assessing regulatory changes can you establish a sound FTO process which will allow you to build and license a strong patent portfolio while minimising risk and saving costs.
Get the answers you need at C5 s 7th International Freedom to Operate 2010 Forum. Bringing you an unparalleled faculty including Bayer, Sandoz, Prosidion, SCA, 4-Antibodies and Ablynx. This conference will provide you with the clarity and information you need to sharpen, refine and evolve your FTO assessment procedures. This is the definitive event for the full analysis of the complex issues and the latest case law surrounding the intersection of IP and competition law and strategies being used by competitors in this progressively heated market.
| |
